Bank of America’s Briacell Therapeutics BCTX Stock Holding History

Bank of America’s Portfolio BCTX Stock Details BCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Hold	0	–	-$8	–	8314
2024 Q4	–	Hold	0	–	–	–	8098
2024 Q3	–	Sell	-119	Closed	-$13.4K	–	7978
2024 Q2	$20.3K	Sell	119 -1	-0.8%	-$283	﹤0.01%	6737
2024 Q1	$51.5K	Buy	120 +1	+0.8%	+$551	﹤0.01%	6506
2023 Q4	$104K	Buy	119 +1	+0.8%	+$718	﹤0.01%	6361
2023 Q3	$110K	Buy	118 +110	+1,375%	+$108K	﹤0.01%	6211
2023 Q2	$7.24K	Buy	8 +6	+300%	+$5.92K	﹤0.01%	6926
2023 Q1	$2.06K	Buy	2 +1	+100%	+$1.04K	﹤0.01%	7214
2022 Q4	$490	Sell	1 -2	-67%	-$1.69K	﹤0.01%	7437
2022 Q3	$3K	Buy	+3	New	+$3.01K	﹤0.01%	7489
2021 Q4	–	Sell	-2	Closed	-$3K	–	8214
2021 Q3	$3K	Sell	2 -147	-99%	-$135K	﹤0.01%	7813
2021 Q2	$119K	Buy	+149	New	+$92.9K	﹤0.01%	6422

Other funds holding BCTX

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CWP

Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HWA

HHM Wealth Advisors Chattanooga, Tennessee $996M AUM 23.11% 1-Year Est. Return

Bank of America's BCTX Position: Q1 2025 in Review

Bank of America held its Briacell Therapeutics (BCTX) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8314.

Bank of America first reported a position in BCTX in Q2 2021 and has held it in 10 quarters since. The position peaked at $119K in Q2 2021. 13 funds tracked by Wall St. Rank hold BCTX as of Q1 2025.

Bank of America held 0 shares of Briacell Therapeutics worth $0 as of Q1 2025.
Bank of America left its Briacell Therapeutics share count unchanged in Q1 2025.
Briacell Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2025, its #8314 holding.
Bank of America first reported a position in Briacell Therapeutics in Q2 2021 and has held it in 10 quarters since.
Bank of America's Briacell Therapeutics position peaked at $119K in Q2 2021.
13 funds tracked by Wall St. Rank held Briacell Therapeutics as of Q1 2025.

Based on Bank of America's 13F filing for Q1 2025, filed 15 May 2025.